
AI that measures and tracks tumors for you.
Click on a lesion on a CT scan anywhere in the body – iMeasure measures and segments it instantly, and tracks it across follow-up scans. Hours of manual work, done in minutes, with outputs you can rely on across readers, sites and timepoints.
< 1s
to get two axial diameters on a selected lesion
mean DICE on kidney lesions – strong across pancreas, lung and liver
organs supported: kidney, pancreas, liver, lung, lymph nodes
drops into any viewer, PACS or reading platform
The problem
Lesion tracking across the body is a tedious, manual and time consuming task.
Measurements are time-intensive and expert-dependent
Measuring target lesions and assessing changes over time takes specialised radiologist time – repeated across every follow-up scan.
Building measurement AI in-house is a distraction
Viewer and platform teams spend years building and validating segmentation models – instead of shipping the workflow their users actually pay for.
High inter- and intra-reader variability
RECIST 1.1 measurements are subjective. Different observers – or the same observer on different days – routinely disagree on the same lesion.
Measurements miss the full picture
Uni-dimensional measurements ignore tumour morphology, density and volume – losing signal that matters for response assessment.
The product
A promptable AI model for solid tumor evaluation, insights and tracking.
Lesion identification
Longitudinal tracking
RECIST-ready measurements
Structured data out, on every call
Segmentation performance
Strong DICE scores across organs – and continuously improving.
2D performance
Kidneys
0.92
Pancreas
0.89
Lungs
0.82
Liver
0.78
Mean DICE. Subject to continuous improvement.
3D performance
Kidneys
0.85
Lungs
0.82
Pancreas
0.81
Liver
0.77
Lymph nodes
0.71
Mean DICE. Subject to continuous improvement.
Use cases
Built to be built in.
iMeasure is sold as an API, designed for the platforms radiologists already work in.
Clinical trial imaging platforms
Standardise RECIST 1.1 reads across sites and readers. Integrate iMeasure into the viewer your CRO customers’ radiologists use – consistent measurements feed your existing response-assessment workflow.
Viewer & PACS component providers
Add one-click lesion measurement and longitudinal tracking to your product – without building and validating an AI pipeline in-house.
Lung cancer screening platforms
Screening means heavy, repetitive reporting across many timepoints. Automated measurement and registration-based tracking cut the per-round reporting load where it’s largest.
Radiotherapy & surgical planning
Organ and lesion segmentation to support planning and to assess change over the course of treatment.
Build with us
Three concrete ways to work with us on iMeasure.
Whether you’re a hospital, a CRO or a pharma sponsor – we’d love to talk about how iMeasure fits your workflow.

API integration
Add lesion segmentation, volumetric measurement and longitudinal tracking to your own viewer – through our API.

BM Viewer
Don’t have a viewer to integrate into? Get iMeasure ready to use in BMViewer, with full RECIST 1.1 reporting built in.

Clinical trial support
Use iMeasure to standardise RECIST 1.1 reads across sites and readers in oncology trials.












